| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.20B | +76.1% |
| Cost of Revenue | $1.26B | +68.1% |
| Gross Profit | -$62.4M | +9.8% |
| R&D Expense | $60.1M | +156.7% |
| SG&A Expense | $116.7M | +205.8% |
| Interest Expense | $2.0M | +40.6% |
| Pre-tax Income | -$287.8M | -79.7% |
| Income Tax | $1.4M | -25.8% |
| Net Income | -$104.5M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $357.3M | +870.1% |
| Short-term Investments | $110.4M | — |
| Accounts Receivable | $86.8M | +85.9% |
| Inventory | $652.7M | +67.5% |
| Current Assets | $1.60B | +142.1% |
| Total Assets | $1.75B | +143.2% |
| Current Liabilities | $1.11B | +43.8% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$282.4M | -6.5% |
| Capital Expenditures | $7.9M | +84.9% |
| Investing Cash Flow | -$148.4M | -565.8% |
| Financing Cash Flow | $817.1M | +253.5% |
| Free Cash Flow | -$290.3M | -7.7% |
| +35.5% |
| EPS (Basic) | -$1.50 | — |
| EPS (Diluted) | -$1.50 | — |
| Total Liabilities |
| $1.12B |
| +44.3% |
| Stockholders' Equity | $435.8M | +351.3% |